In SAFE-HEaRt (Cardiac Safety Study in Patients With HER2 + Breast Cancer), 30 women with HER2-positive breast cancer and mildly reduced LVEFs (ie, between 40% and 50%) and no symptoms of heart failure were enrolled. Here, ERBB2 is linked to breast carcinoma.